¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infant carbohydrate intake"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® carbohydrate ÇÑ±Û Åº¼öÈ­¹°
¼³¸í   
  Åº¼Ò¿Í ¹°ºÐÀڷΠÀÌ·ç¾îÁø À¯±âÈ­ÇÕ¹°. »ï´ë¿µ¾ç¼Ò °¡¿îµ¥ Çϳª·Î, ³ì»ö½Ä¹°ÀÇ ±¤ÇÕ¼ºÀ¸·Î »ý±ä´Ù. Æ÷µµ´ç, °ú´ç, ³ì¸» µûÀ§°¡ ÀÖ´Ù. ÀϹÝÀûÀ¸·Î Åº¼Ò-¼ö¼Ò-»ê¼ÒÀÇ ¼¼ ¿ø¼Ò·Î ÀÌ·ç¾îÁö´Â È­ÇÕ¹°·Î, ³ÐÀº ¶æÀ¸·Î´Â ´ç·ù-´çÁú°ú °°Àº ¶æÀ¸·Î ¾²ÀδÙ. ÀϹݽÄ(Cn(H2O)nÀÌ ¸¶Ä¡ Åº¼Ò¿Í ¹°ºÐÀÚ(H2O)·Î ÀÌ·ç¾îÁ® Àִ °Íó·³ º¸À̱⠶§¹®¿¡ ÀÌ·± À̸§ÀÌ ºÙ¾ú´Ù. ±×¸®°í »ê¼Ò ¿øÀÚ¼ö°¡ ÀϹݽĺ¸´Ù Çϳª ÀûÀº °Í, Áú¼Ò¿øÀÚ¸¦ ÇÔÀ¯Çϴ °Í, È²È­ÇÕ¹°À» ÇÔÀ¯Çϴ °Íµµ Åº¼öÈ­¹°¿¡ Æ÷ÇÔ½ÃŲ´Ù. È­ÇÐÀûÀ¸·Î´Â ´Ù°¡ ¾ËÄÚ¿ÃÀÇ ¾Ëµ¥È÷µå ¶Ç´Â ÄÉÅæ ¹× ±× À¯µµÃ¼ÀÇ ÃÑĪÀÌ´Ù.
¿µ¹® premature infant ÇÑ±Û ¹Ì¼÷¾Æ, Á¶»ê¾Æ
¼³¸í   
  »ýÁ¸°¡´É ÇѰè ÀÌÈÄ¿¡, Á¤±â Ãâ»êÀÇ ½Ã±â ÀÌÀü¿¡ ÀÚ¿¬ÀûÀ̰ųª ÀΰøÀûÀ¸·Î ºÐ¸¸Çϴ °ÍÀ» Á¶»êÀ̶ó°í Çϸç, ±× °á°ú Å¾ ¾ÆÀ̸¦ Á¶»ê¾Æ¶ó°í ¸»ÇÑ´Ù. WHO¿¡¼­´Â 28~37ÁÖ¿¡ Å¾ ¾Æ±â¶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ÇöÀç »ýÁ¸°¡´É ÇѰè´Â ÀÇ·á±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ±× ÇѰ迪ÀÌ ³ÐÇôÁö°í ÀÖ´Ù. Á¶»ê¾ÆÀÇ ´ëºÎºÐÀº ÀúüÁß¾Æ(2,500g ÀÌÇÏ)·Î Ãâ»ýÇϱ⠶§¹®¿¡ °¢ Àå±â±â´ÉÀÌ ÃæºÐÇϰԠ¼º¼÷µÇ¾î ÀÖÁö ¾Ê¾Æ »ýÈÄ¿¡ È£Èí, °£, ÄáÆÏ µîÀÇ ±â´ÉÀå¾Ö¸¦ ¹ß»ýÇϴ ÀÏÀÌ ¸¹´Ù. º¸À°±â¿¡ ÀÇÇÑ °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ìµµ ÀÖ´Ù. ¾î¸®°Å³ª ³ªÀÌ ¸¹Àº ÀÓºÎÀÇ Ãʻ꿡 ¸¹´Ù.
¿µ¹® newborn infant ÇÑ±Û ½Å»ý¾Æ
¼³¸í   
  ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö Àִ ´É·ÂÀ» È¹µæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼­ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼­ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇϰԠµÇ´Â ±Þ°ÝÇÑ º¯È­°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼­ ÃʱâÀǠü¿ÂÀÇ °­ÇÏ, »ý¸®Àû Ã¼ÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾ´Ù. °¨°¢¸é¿¡¼­´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°­ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °­ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°Çϴ Á¤µµÀ̸ç, Ã»°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù.
¿µ¹® infant ÇÑ±Û ¿µ¾Æ, À¯¾Æ, Á¥¸ÔÀÌ
¼³¸í   
  ½Å»ý¾Æ¸¦ Æ÷ÇÔÇØ Ãâ»ý ÈÄ 1³â±îÁöÀÇ ¾î¸°À̸¦ ¸»Çϸç ÀÌ ±â°£À» ¿µ¾Æ±â¶ó ºÎ¸¥´Ù. ½Åü¹ßÀ° ¹× ¿îµ¿±â´ÉÀÇ ¹ß´ÞÀÌ ¸Å¿ì È°¹ßÇÑ ½Ã±âÀÌ´Ù. ÀÌ ½Ã±â´Â ½Å»ý¾Æ ¶§ºÎÅÍ °è¼ÓÇØ¼­ È¯°æ¿¡ ÀûÀÀÇØ °¡´Â Áß¿äÇÑ ½Ã±âÀÌ´Ù. Á¥´Ï°¡ ³ª¿À¸ç ¸é¿ª±â´ÉÀǠȰ¼ºÈ­, ¹Ý»çÀÇ ¼Ò½Ç°ú ¼öÀǿÀÇ ¹ß´Þ, °¨°¢(½Ã°¢, Ã»°¢, Ã˰¢) ±â´ÉÀÇ ¹ß´Þ, Ã¼Áß°ú Å°ÀÇ Áõ°¡¸¦ È®ÀÎÇÒ ¼ö ÀÖ´Ù. Ã¼ÁßÀº 3°³¿ù¿¡ 2¹è, 1³â¿£ 3¹è°¡ µÇ¸ç, Å°´Â 1³â¿¡ ¾à 27cm ÀÚ¶õ´Ù.
¿µ¹® sudden infant death syndrome ÇÑ±Û ¿µ¾Æ±Þ»çÁõÈıº
¼³¸í   
  ÇÑ »ì ÀÌÇÏÀÇ °Ç°­ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀΠ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼­ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°­°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀΠ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate broth
    ź¼öÈ­¹°Áó
  • carbohydrate intolerance
    ź¼öÈ­¹°¸ø°ßµõ(Áõ), ź¼öÈ­¹°ºÒ³»¼º
  • acceptable daily intake
    ÀÏÀϼ·ÃëÇã¿ë·®
  • caloric intake
    Ä®·Î¸®¼·Ãë, ¿­·®¼·Ãë
  • deficient intake
    ¼·ÃëºÎÁ·
  • excessive intake
    °úÀ×¼·Ãë
  • food intake
    ¼·½Ä, ½Äǰ¼·Ãë
  • intake
    ¼·Ãë, ¼·Ãë·®
  • intake and output record
    ¼·Ãë¹è¼³·®±â·Ï
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • oral intake
    °æ±¸¼·Ãë
  • Cattell infant intelligence scale
    Ä¿ÅÚ¿µ¾ÆÁö´Éôµµ
  • floppy infant
    ´Ã¾îÁø¿µ¾Æ, ±ÙÀ°±äÀåÀúÇÏ¿µ¾Æ, Àú±äÀ念¾Æ
  • floppy infant syndrome
    Àú±äÀ念¾ÆÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ź¼öÈ­¹°
  • intake
    ¼·Ãë, ¼·Ãë·®
  • oral intake
    °æ±¸¼·Ãë
  • infant
    ¿µ¾Æ, À¯¾Æ, Á¥¸ÔÀÌ
  • premature infant
    ¹Ì¼÷¾Æ, Á¶»ê¾Æ
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü
  • Floppy infant syndrome
    Àú±äÀ徯ÁõÈıº, ±äÀåÀúÇÏ¿µ¾ÆÁõÈıº
  • sudden infant death syndrome
    ¿µ¾Æ±Þ»çÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate broth
    ź¼öÈ­¹°Áó
  • carbohydrate
    ź¼öÈ­¹°
  • carbohydrate disk
    ź¼öÈ­¹°¿ø¹Ý, ź¼öÈ­¹°µð½ºÅ©
  • carbohydrate intolerance
    ´çÁú¸ø°ßµõ(Áõ)
  • carbohydrate malabsorption syndrome
    ´çÁúÈí¼öºÒ·®ÁõÈıº
  • carbohydrate tolerance test
    ź¼öÈ­¹°³»¼º½ÃÇè
  • acceptable daily intake
    ÀÏÀϼ·ÃëÇã¿ë·®
  • caloric intake
    Ä®·Î¸®¼·Ãë, ¿­·®¼·Ãë
  • deficient intake
    ¼·ÃëºÎÁ·
  • excessive intake
    °úÀ×¼·Ãë
  • food intake
    ¼·½Ä, ½Äǰ¼·Ãë
  • intake
    ¼·Ãë, ¼·Ãë·®
  • intake and output record
    ¼·Ãë¹è¼³·®±â·Ï
  • intake excretion test
    ¼·Ãë¹è¼³°Ë»ç
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptable daily intake =ADI
    ÀÏÀϼ·ÃëÇã¿ë·®(ìéìíàîö¢úÉé»åÖ).
  • annual limit on intake (ALI)
    ¿¬°£Èí¼öÁ¦ÇÑ, ¿¬°£Èí¼öÇѵµ
  • group specific C carbohydrate
    ±ºÆ¯ÀÌ C´Ù´çü.
  • group-specific C carbohydrate
    ±ºÆ¯ÀÌ C ź¼öÈ­¹°
  • Cattell infant intelligence scale
    Ä«ÅÚ¿µ¾Æ Áö´É°èÃø.
  • IRDNI=£¾idiopathic respiratory distress of the newborn infant
    ½Å»ý¾Æ Ư¹ß¼º È£Èí°ï¶õÁõ, À¯¸®Áú¸·Áõ.
  • Infant
    Á¥¸ÔÀÌ
  • high risk infant
    °íÀ§Ç輺 ¿µ¾Æ.
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
  • immature infant
    ¹Ì¼÷¾Æ(Ú±âÙä®).
  • infant
    ¿µ¾Æ(¿µä®)
  • infant at full term =t. f.
    ¸¸±â»ê¾Æ(ػѢ ß§ä®).
  • infant botulism
    À¯¾Æº¸Åø¸®´®Áõ
  • infant circle
    À¯¾Æ¿ë ¼øÈ¯(½Ä)ȸ·Î, ¼Ò¾Æ¼øÈ¯È¸·Î.
  • infant day care
    ¿µ¾Æ ÁÖ°£ °¡·á
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptable daily intake =ADI
    ÀÏÀϼ·ÃëÇã¿ë·®(ìéìíàîö¢úÉé»åÖ).
  • annual limit on intake (ALI)
    ¿¬°£Èí¼öÁ¦ÇÑ, ¿¬°£Èí¼öÇѵµ
  • caloric intake
    Ä®·Î¸®¼·Ãë, ¿­·®¼·Ãë, ½Ä»ç¼·Ãë(·®)(ãÝÞÀàîö¢åÖ).
  • deficient intake
    ¼·ÃëºÎÁ·(àîö¢ÝÕðë).
  • excessive intake
    °úÀ×¼·Ãë(¡­àîö¢).
  • food intake
    ¼·½Ä(àîãÝ), ½Äǰ¼·Ãë, ¼·»ç·®.
  • food intake
    ¼·½Ä(àîãÝ), ½Äǰ¼·Ãë(ãÝù¡àîö¢), ¼·»ç·®(àîÞåÕá).
  • food intake
    ¼·½Ä(ËÛËà), ½Äǰ¼·Ãë, ¼·»ç·®.
  • intake
    ¼·Ãë(àîö¢).
  • intake and output record
    ¼·Ãë¿Í ¹è¼³·® ±â·Ï.
  • intake excretion test
    ¼·Ãë¹è¼³½ÃÇè.
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ìéìíàîö¢õÌÓÞúÉé»åÖ).
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ËöËöËÛ̧̬ËÀÌ´ËíËâ).
  • oral intake
    °æ±¸(Àû) ¼·Ãë(ÌèÏ¢îÜàîö¢).
  • oxygen intake =o. uptake
    »ê¼Ò¼·Ãë(·®) (¡­àîö¢åÖ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Metabolic defect of carbohydrate (Galactosemia)
    ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
    [¿¾ ¿ë¾î] ź¼öÈ­¹°´ë»ç°áÇÔ(°¥¶ôÅä¿À½ºÇ÷Áõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caloric intake
    Ä®·Î¸® ¼·Ãë(àîö¢)
  • active carbohydrate
    Ȱ¼º´çÁú (üÀàõÓØòõ)
  • carbohydrate
    ´çÁú(ÓØòõ)
  • carbohydrate tolerance test
    ´çÁú ºÎÇϽÃÇè(ÓØòõݶùÃãËúÐ)
  • derived carbohydrate
    À¯µµ´çÁú(ë¯ÓôÓØòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ´çÁú, ź¼öÈ­¹°
  • intake
    ¼·Ãë
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • oral intake
    °æ±¸(Àû)¼·Ãë
  • infant
    ¿µ¾Æ, À¯¾Æ
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • infant mobilization device
    ¿µ¾Æ À̵¿ÀåÄ¡
  • newborn infant
    ½Å»ý¾Æ
  • premature infant
    ¹Ì¼÷¾Æ, Á¶»ê¾Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ADI Academy of Dentistry International; acceptable daily intake; AIDS-defining illness; allowable daily ...
DPI daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni...
IMR individual medical record; infant mortality rate; infant mortality risk; Institute for Medical Resea...
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
I & O Intake & Output; ¼·Ãë·®°ú ¹è¼³·®
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BSID Bayley Scale of Infant Development
IMR Infant Mortality Rate
NMIHS National Maternal and Infant Health Survey
SID Sudden Infant Death
SIDS Suddern Infant Death Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acceptable daily intake
    ÀÏÀÏ ¼·Ãë Çã¿ë·®
  • caloric intake
    Ä®·Î¸® ¼·Ãë, ¿­·® ¼·Ãë, ½Ä»ç ¼·Ãë, ½Ä»ç ¼·Ãë·®
  • fluid intake
    ¼ö¾× ¼·Ãë
  • intake
    ¼·Ãë
    ¾î¶² ¹°ÁúÀ» ½Åü ³»·Î ÃëÇÏ´Â °Í.
  • oral intake
    °æ±¸ ¼·Ãë, °æ±¸Àû ¼·Ãë
  • carbohydrate
    ´çÁú, ź¼öÈ­¹°
    ´Ù°¡ ¾ËÄÝ, ƯÈ÷ 5°¡ ¹× 6°¡ ¾ËÄÝÀÇ ¾Ëµ¥ÇÏÀ̵å ȤÀº Űſ À¯µµÃ¼ ¼ö¼Ò¿Í »ê¼Ò°¡ º¸Åë ¹°°ú °°Àº ºñÀ²·Î ÇÔÀ¯µÇ¹Ç·Î
  • carbohydrate fermentation test
    ź¼öÈ­¹° ¹ßÈ¿ ½ÃÇè
  • carbohydrate intolerance
    ´çÁú ºÒ³»¼º
  • carbohydrate metabolism disorder
    ź¼öÈ­¹° ´ë»ç Àå¾Ö
  • carbohydrate tolerance
    ź¼öÈ­¹° ºÎÇÏ, ź¼öÈ­¹° ³»Àμº
  • carbohydrate utilization test
    ź¼öÈ­¹° ÀÌ¿ë ½ÃÇè
  • immature infant
    ¹Ì¼÷¾Æ
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
    ¿µ¾Æ±â·ÎºÎÅÍ »çÃá±â±îÁöÀÇ »ç¶÷.
  • infant feeding
    ¿µ¾Æ ¿µ¾ç
  • infant nutrition
    ¿µ¾ß ¿µ¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acceptable daily intake <pharmacology> This is an estimate of the amount of a substance in food that can be ingested daily over a lifetime by humans without appreciable health risk.
The concept of the acceptable daily intake has been developed principally by who and FAO and is relevant to chemicals such as additives to foods, residues of pesticides and veterinary drugs in foods.
Acceptable daily intakes are derived from laboratory toxicity data, and from human experiences of such chemicals when this is available, and incorporate a safety factor. The acceptable daily intake is thus an estimate of the amount of a substance in food that can be ingested over a lifetime by humans without significant risk to health (for contaminants in food and drinking water, tolerable intakes - daily or weekly - are used).
See: tolerable daily intake.
(15 Jan 1998)
tolerable daily intake TDIs are applied to chemical contaminants in food and drinking water. The presence of contaminants is unwanted and they have no useful function, differing from additives and residues where there is or was deliberate use resulting in their presence. TDIs are calculated on the basis of laboratory toxicity data with the application of uncertainty factors. A TDI is therefore an estimate of the amount of a substance (contaminant) in food or drinking water that can be ingested daily over a lifetime without a significant health risk.
(09 Oct 1997)
energy intake Total number of calories taken in daily whether ingested or by parenteral routes.
(12 Dec 1998)
antigens, tumour-associated, carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
(12 Dec 1998)
carbohydrate <biochemistry> Very abundant compounds, usually an aldehyde or ketone derivative of a polyhydric alcohol, particularly of the pentahydric and hexahydric alcohols. They are so named because the hydrogen and oxygen are usually in the proportion to form water with the general formula Cn(H2O)n. The most important carbohydrates are the starches, sugars, celluloses and gums.
They are classified into mono, di, tri, poly and heterosaccharides. The smallest are monosaccharides like glucose whereas polysaccharides such as starch, cellulose or glycogen can be large and indeterminate in length.
(08 Oct 1997)
carbohydrate conformation The characteristic 3-dimensional shape of a carbohydrate.
(12 Dec 1998)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
carbohydrate dehydrogenases <enzyme> Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted.
Registry number: EC 1.1.
(12 Dec 1998)
carbohydrate epimerases <enzyme> Enzymes that catalyze the epimerization of chiral centres within carbohydrates or their derivatives.
Registry number: EC 5.1.3
(12 Dec 1998)
carbohydrate-induced hyperlipaemia type III familial hyperlipoproteinaemia, type IV familial hyperlipoproteinaemia
carbohydrate loading A procedure popular with long-distance runners and other athletes of filling muscles with a large glycogen pool prior to an athletic event; often, the athlete consumes very few carbohydrates for three days followed by a largely carbohydrate diet for the last three days before the event.
(05 Mar 2000)
carbohydrate metabolism <biochemistry> The breakdown of starches and sugars into smaller units that can be used by the body for energy.
(27 Sep 1997)
carbohydrate sequence The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids.
(12 Dec 1998)
carbohydrate utilization test A test for the definitive identification of clinically important yeasts and yeastlike organisms.
(05 Mar 2000)
C carbohydrate antigen An antigen found in the cell wall of Streptococcus pneumoniae.
See: beta-haemolytic streptococci.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbohydrate
    ź¼öÈ­¹°
  • intake
    ¾î±Í; ¼·Ãë·®; ÈíÀÔ·®
  • carbohydrate
    ź¼öÈ­¹°;ÇÔ¼öź¼Ò;ź¼öÈ­¹°ÀÌ ¸¹Àº ½Äǰ
  • intake
    (¹°,°ø±â µîÀ»)¹Þ¾ÆµéÀ̴°÷;(ź°»µîÀÇ)Åëdz±¸¸Û;»¡¾ÆµéÀÌ´Â ¾ç;¼·Ãë·®;¼öÀÔ;¸ÅÃâ¾×;ä¿ëÀοø(¼ö);(Àß·èÇϰÔ)Á¼¾ÆÁø ºÎºÐ(narrowing);¸Å¸³Áö(´ËÀ̳ª ¸øÀÇ)
  • infant
    À¯¾Æ
  • infant
    À¯¾Æ;À¯¾Æ;¼Ò¾Æ(7¼¼¹Ì¸¸);(¹ý)¹Ì¼º³âÀÚ(¹Ì 21¼¼ ¹Ì¸¸,¿µ¿¡¼­´Â 18¼¼¹Ì¸¸);À¯¾ÆÀÇ;¼Ò¾ÆÀÇ;À¯¾Æ¿ë;À¯Ä¡ÇÑ;ÃʱâÀÇ;(¹ý)¹Ì¼º³âÀÇ
  • infant mortality
    (1¼¼¹Ì¸¸ÀÇ)À¯¾Æ»ç¸Á·ü 
  • infant(infantile) prodigy
    (õÀç¾Æ,½Åµ¿)
  • infant(s') school
    (¿µ)À¯¾ÆÇб³ ±¹¹ÎÇб³;À¯¾ÆºÎ(º¸Åë 5-7¼¼ÀÇ Àǹ« ±³À°Çб³)cf.KINDERGARTEN;PRIMARY SCHOOL
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á